Gert Rijksen

5.0k total citations
151 papers, 4.2k citations indexed

About

Gert Rijksen is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Gert Rijksen has authored 151 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 40 papers in Cancer Research and 37 papers in Physiology. Recurrent topics in Gert Rijksen's work include Cancer, Hypoxia, and Metabolism (34 papers), Erythrocyte Function and Pathophysiology (32 papers) and Pancreatic function and diabetes (21 papers). Gert Rijksen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (34 papers), Erythrocyte Function and Pathophysiology (32 papers) and Pancreatic function and diabetes (21 papers). Gert Rijksen collaborates with scholars based in Netherlands, Hungary and United States. Gert Rijksen's co-authors include G.E.J. Staal, René H. Medema, Veronique A. J. Smits, Rob Klompmaker, A. Hennipman, Gerrit Jansen, Thea M. Vroom, Paschal A. Oude Weernink, G. E. J. Staal and Lionel Arnaud and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Gert Rijksen

149 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gert Rijksen Netherlands 32 2.7k 1.2k 713 626 561 151 4.2k
Maria Rita Nicotra Italy 42 2.3k 0.8× 1.3k 1.0× 454 0.6× 577 0.9× 524 0.9× 79 4.3k
Anne E. Cress United States 41 2.8k 1.0× 1.8k 1.4× 904 1.3× 931 1.5× 222 0.4× 147 5.4k
Germán Pihán United States 26 2.3k 0.8× 1.0k 0.8× 1.1k 1.5× 500 0.8× 162 0.3× 76 4.1k
Frank Hilberg Austria 28 2.0k 0.7× 1.1k 0.9× 286 0.4× 497 0.8× 240 0.4× 57 4.0k
Jeffrey N. Fitzner United States 13 2.1k 0.8× 1.6k 1.3× 310 0.4× 1.1k 1.8× 366 0.7× 14 5.1k
Henrik Daub Germany 35 5.4k 2.0× 1.7k 1.4× 1.1k 1.6× 524 0.8× 366 0.7× 56 7.6k
Abdel‐Majid Khatib France 32 1.7k 0.6× 1.0k 0.8× 631 0.9× 809 1.3× 182 0.3× 96 3.4k
Martijn F.B.G. Gebbink Netherlands 34 2.4k 0.9× 424 0.3× 412 0.6× 549 0.9× 505 0.9× 60 4.0k
P. Linga Reddy India 12 2.0k 0.7× 1.5k 1.2× 289 0.4× 1.0k 1.6× 368 0.7× 13 4.7k
Hirofumi Arakawa Japan 37 4.2k 1.5× 2.5k 2.0× 498 0.7× 1.1k 1.8× 199 0.4× 68 6.0k

Countries citing papers authored by Gert Rijksen

Since Specialization
Citations

This map shows the geographic impact of Gert Rijksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Rijksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Rijksen more than expected).

Fields of papers citing papers by Gert Rijksen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert Rijksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Rijksen. The network helps show where Gert Rijksen may publish in the future.

Co-authorship network of co-authors of Gert Rijksen

This figure shows the co-authorship network connecting the top 25 collaborators of Gert Rijksen. A scholar is included among the top collaborators of Gert Rijksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert Rijksen. Gert Rijksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rijksen, Gert, et al.. (2007). Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. Journal of Oral Pathology and Medicine. 27(4). 147–152. 30 indexed citations
2.
Vooght, Karen M. K. de, et al.. (2002). [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].. PubMed. 146(39). 1828–31. 2 indexed citations
3.
Rijksen, Gert, et al.. (2001). Mutations in the human pyruvate kinase gene leading to pyruvate kinase deficiency, in the Netherlands.. Data Archiving and Networked Services (DANS). 2 indexed citations
4.
Smits, Veronique A. J., Rob Klompmaker, Tea Vallenius, et al.. (2000). p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint. Journal of Biological Chemistry. 275(39). 30638–30643. 172 indexed citations
5.
Verdonck, Leo F., et al.. (1999). CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. European Journal of Immunology. 29(3). 789–798. 61 indexed citations
6.
Smits, Veronique A. J., et al.. (1999). Inhibition of cell proliferation by lithium is associated with interference in cdc2 activation. FEBS Letters. 457(1). 23–27. 24 indexed citations
7.
Oijen, Monique G.C.T. van, et al.. (1998). Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncology. 34(4). 297–303. 29 indexed citations
8.
Oijen, Monique G.C.T. van, René H. Medema, Pieter J. Slootweg, & Gert Rijksen. (1998). Positivity of the Proliferation Marker Ki-67 in Noncycling Cells. American Journal of Clinical Pathology. 110(1). 24–31. 119 indexed citations
9.
Heyden, Marcel A. G. van der, et al.. (1997). The Actin Binding Domain of the Epidermal Growth Factor Receptor Is Required for EGF-Stimulated Tissue Invasion. Experimental Cell Research. 234(2). 521–526. 24 indexed citations
10.
Oirschot, Brigitte A. van, et al.. (1995). Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer. Breast Cancer Research and Treatment. 33(3). 245–256. 19 indexed citations
11.
Verschuur, Hendrik P., Gert Rijksen, Brigitte A. van Oirschot, et al.. (1994). Protein tyrosine (de-) phosphorylation in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 251(1). 12–16. 8 indexed citations
12.
Elbers, J. R. J., et al.. (1991). Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer. 67(10). 2552–2559. 20 indexed citations
13.
Rijksen, Gert, et al.. (1991). Cellular expression of K-type pyruvate kinase in normal and neoplastic human tissues. Cancer. 68(12). 2595–2601. 3 indexed citations
14.
Jansen, Gerrit, et al.. (1988). Expression of a membrane folate binding protein in human leukemic ccrf cem cells resistant to methotrexate by virtue of impaired transport. 29. 303. 1 indexed citations
15.
Veelen, C.W.M. van, Gert Rijksen, & G. E. J. Staal. (1988). Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis. Acta Neurochirurgica. 91(3-4). 126–129. 3 indexed citations
16.
Weernink, Paschal A. Oude, Gert Rijksen, & G.E.J. Staal. (1988). Production of a specific antibody against pyruvate kinase type M2 using a synthetic peptide. FEBS Letters. 236(2). 391–395. 4 indexed citations
17.
Hennipman, A., et al.. (1988). Heterogeneity of Glycolytic Enzyme Activity and Isozyme Composition of Pyruvate Kinase in Breast Cancer. Tumor Biology. 9(4). 178–189. 26 indexed citations
18.
Hennipman, A., et al.. (1988). Glycolytic Enzyme Activities in Breast Cancer Metastases. Tumor Biology. 9(5). 241–248. 49 indexed citations
19.
Staal, G.E.J., et al.. (1987). Tyrosine kinase activity in breast cancer, benign breast disease and normal breast tissue. Journal of Steroid Biochemistry. 28. 29–29. 1 indexed citations
20.
Veelen, C.W.M. van, et al.. (1982). Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas. Acta Neurochirurgica. 61(1-3). 145–159. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Rita Nicotra Breakdown of academic impact, for papers by Anne E. Cress Breakdown of academic impact, for papers by Germán Pihán Breakdown of academic impact, for papers by Frank Hilberg Breakdown of academic impact, for papers by Jeffrey N. Fitzner Breakdown of academic impact, for papers by Henrik Daub Breakdown of academic impact, for papers by Abdel‐Majid Khatib Breakdown of academic impact, for papers by Martijn F.B.G. Gebbink Breakdown of academic impact, for papers by P. Linga Reddy Breakdown of academic impact, for papers by Hirofumi Arakawa
Rankless by CCL
2026